Contract research organisation Quintiles Transnational has pulled back from plans to seek $2.4 billion in financing, saying that conditions in …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

